109 related articles for article (PubMed ID: 1764176)
1. Estimation of doses to heart, coronary arteries, and spinal cord in mediastinal irradiation for Hodgkin's disease.
Vijayakumar S; Rosenberg I; Spelbring D; Brandt T
Med Dosim; 1991 Dec; 16(4):237-41. PubMed ID: 1764176
[TBL] [Abstract][Full Text] [Related]
2. 3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.
Vordermark D; Seufert I; Schwab F; Kölbl O; Kung M; Angermann C; Flentje M
Radiat Oncol; 2006 Apr; 1():10. PubMed ID: 16722610
[TBL] [Abstract][Full Text] [Related]
3. Quantification of doses to mediastinal lymph nodes in Hodgkin's disease.
Vijayakumar S; Rosenberg I; Brandt T; Spelbring D; Rubin S
Med Dosim; 1992; 17(2):87-94. PubMed ID: 1616597
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma.
Paumier A; Ghalibafian M; Gilmore J; Beaudre A; Blanchard P; el Nemr M; Azoury F; al Hamokles H; Lefkopoulos D; Girinsky T
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1522-7. PubMed ID: 21705151
[TBL] [Abstract][Full Text] [Related]
6. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
[TBL] [Abstract][Full Text] [Related]
7. Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction.
Hahn E; Jiang H; Ng A; Bashir S; Ahmed S; Tsang R; Sun A; Gospodarowicz M; Hodgson D
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1116-1123. PubMed ID: 28721895
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
9. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease.
King V; Constine LS; Clark D; Schwartz RG; Muhs AG; Henzler M; Hutson A; Rubin P
Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):881-9. PubMed ID: 8960517
[TBL] [Abstract][Full Text] [Related]
11. Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients.
Rademaker J; Schöder H; Ariaratnam NS; Strauss HW; Yahalom J; Steingart R; Oeffinger KC
AJR Am J Roentgenol; 2008 Jul; 191(1):32-7. PubMed ID: 18562721
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy for lymphoma involving the mediastinum.
Goodman KA; Toner S; Hunt M; Wu EJ; Yahalom J
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):198-206. PubMed ID: 15850922
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of incorporating heterogeneity corrections in mantle field irradiation.
Kirsner SM; Kudchadker RJ; Prado KL; Ha CS; Wilder RB; Cox JD
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1135-42. PubMed ID: 12605993
[TBL] [Abstract][Full Text] [Related]
14. Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study).
Jacob S; Camilleri J; Derreumaux S; Walker V; Lairez O; Lapeyre M; Bruguière E; Pathak A; Bernier MO; Laurier D; Ferrieres J; Gallocher O; Latorzeff I; Pinel B; Franck D; Chevelle C; Jimenez G; Broggio D
Radiat Oncol; 2019 Feb; 14(1):29. PubMed ID: 30732640
[TBL] [Abstract][Full Text] [Related]
15. [Influence of reduction of radiation dosage on the incidence of radiation-induced pneumonitis, pulmonary fibrosis and pericarditis after mediastinal irradiation in the treatment of lymphogranulomatosis].
Libera T; Mücke R; Cihal S; Knauerhase H; Ziegler PG; Hamann D; Kundt G; Strietzel M
Strahlenther Onkol; 1997 Jun; 173(6):330-4. PubMed ID: 9235640
[TBL] [Abstract][Full Text] [Related]
16. [Radiotherapy in adults with localized supradiaphragmatic stages CS I/II of Hodgkin's disease. 2. The special aspects of radiotherapy: dosage, fractionation, focal volumes, risks, conclusions].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Oct; 169(10):570-83. PubMed ID: 8235981
[TBL] [Abstract][Full Text] [Related]
17. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease.
Heidenreich PA; Schnittger I; Strauss HW; Vagelos RH; Lee BK; Mariscal CS; Tate DJ; Horning SJ; Hoppe RT; Hancock SL
J Clin Oncol; 2007 Jan; 25(1):43-9. PubMed ID: 17194904
[TBL] [Abstract][Full Text] [Related]
18. [Coronary disease after the radiotherapy of the mediastinum in Hodgkin's disease].
Martí V; López Morales J; Bailén JL; Augé JM
Rev Clin Esp; 1991 Jun; 189(1):26-8. PubMed ID: 1924923
[TBL] [Abstract][Full Text] [Related]
19. Cardiac chamber and coronary artery doses associated with postmastectomy radiotherapy techniques to the chest wall and regional nodes.
Krueger EA; Schipper MJ; Koelling T; Marsh RB; Butler JB; Pierce LJ
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1195-203. PubMed ID: 15519792
[TBL] [Abstract][Full Text] [Related]
20. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk.
Koh ES; Tran TH; Heydarian M; Sachs RK; Tsang RW; Brenner DJ; Pintilie M; Xu T; Chung J; Paul N; Hodgson DC
Radiat Oncol; 2007 Mar; 2():13. PubMed ID: 17362522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
